China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Sunday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

China Pharma stock opened at $0.22 on Friday. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The stock has a fifty day moving average price of $0.20 and a two-hundred day moving average price of $0.21. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.